Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Dubbert

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Clinical Psychiatry|October 1, 1994
Obsessive compulsive disorder: comorbid conditionsT A Pigott, F L'Heureux, B Dubbert, et al.
Biological Psychiatry|March 1, 1993
Lack of evidence for Huntington's disease-like cognitive dysfunction in obsessive-compulsive disorderA Martin, T A Pigott, F M Lalonde, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1996
Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this timeM A Magiakou, G Mastorakos, D Rabin, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1997
The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolismL D Dorn, E S Burgess, T C Friedman, et al.
Archives of General Psychiatry|January 1, 1992
Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorderM Altemus, T Pigott, K T Kalogeras, et al.
Child and Adolescent Psychiatric Clinics of North America|August 12, 1999
Postinfectious and other forms of obsessive-compulsive disorderH L Leonard, S E Swedo, M Garvey, et al.
Psychiatry Research|August 30, 1996
Biological and behavioral responses to D-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteersT A Grady, A Broocks, S K Canter, et al.
Anxiety|January 1, 1994
Sertraline in the treatment of patients with social phobiaE A Martins, T A Pigott, S E Bernstein, et al.
Biological Psychiatry|April 9, 1998
The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controlsA Broocks, J T Little, A Martin, et al.
Clinical Endocrinology|October 1, 1995
Psychopathology in patients with endogenous Cushing's syndrome: 'atypical' or melancholic featuresL D Dorn, E S Burgess, B Dubbert, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Psychiatry|October 1, 1994
Obsessive compulsive disorder: comorbid conditionsT A Pigott, F L'Heureux, B Dubbert, et al.
Biological Psychiatry|March 1, 1993
Lack of evidence for Huntington's disease-like cognitive dysfunction in obsessive-compulsive disorderA Martin, T A Pigott, F M Lalonde, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1996
Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this timeM A Magiakou, G Mastorakos, D Rabin, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1997
The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolismL D Dorn, E S Burgess, T C Friedman, et al.
Archives of General Psychiatry|January 1, 1992
Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorderM Altemus, T Pigott, K T Kalogeras, et al.
Child and Adolescent Psychiatric Clinics of North America|August 12, 1999
Postinfectious and other forms of obsessive-compulsive disorderH L Leonard, S E Swedo, M Garvey, et al.
Psychiatry Research|August 30, 1996
Biological and behavioral responses to D-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteersT A Grady, A Broocks, S K Canter, et al.
Anxiety|January 1, 1994
Sertraline in the treatment of patients with social phobiaE A Martins, T A Pigott, S E Bernstein, et al.
Biological Psychiatry|April 9, 1998
The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controlsA Broocks, J T Little, A Martin, et al.
Clinical Endocrinology|October 1, 1995
Psychopathology in patients with endogenous Cushing's syndrome: 'atypical' or melancholic featuresL D Dorn, E S Burgess, B Dubbert, et al.
Pageof 2